Moderna (MRNA) Faces Multiple Regulatory Challenges
On May 31, Bloomberg reported that the FDA recently granted Moderna Inc. (NASDAQ:MRNA) a narrower approval for its next-generation COVID-19 vaccine.
Posts Tagged ‘Moderna Inc. (NASDAQ:MRNA)’
Jim Cramer on Moderna (MRNA): “I’ve Been Against This Stock For So Long”
We recently published a list of Jim Cramer Talked About These 13 Stocks. In this article, we are going to take a look at where Moderna, Inc.
Jim Cramer Talked About These 13 Stocks
“If you want to know what makes a successful retailer, all you have to do is read the conference calls. Everything's on display, no secret sauces.
Moderna, Inc. (MRNA) Submits Updated COVID Vaccine for Regulatory Review
Moderna, Inc. (NASDAQ:MRNA) announced on Friday that it has submitted a marketing application to the U.S.
Why Moderna, Inc. (MRNA) Crashed Today
We recently published a list of 10 Firms Drenched in Red Today.
Why Moderna, Inc. (MRNA) Skyrocketed Today
We recently published a list of These 10 Firms Just Beat the Market Today.
Moderna Leads S&P 500 After FDA Eases Booster Concerns
Moderna, Inc. (NASDAQ:MRNA) shares soared to the top of the S&P 500 gainers in early afternoon trading on May 20, surging by 11%. The rise followed the U.S.
Why Moderna, Inc. (MRNA) Surged Today
We recently published a list of 10 Stocks That Stole the Show Today.
How Did These 10 Predictions By Jim Cramer Turn Out?
He emphasized that natural gas is heavily influenced by federal policy, especially when it comes to exports.
Was Jim Cramer Right About Moderna (MRNA) Stock?
Back in 2024, on May 14, Mad Money’s Jim Cramer was asked about Moderna, Inc.
12 Best Growth Stocks to Buy and Hold for the Long Term
The market closed last week mostly lower, however, the S&P 500 has been up more than 7% since April 11, indicating a returning positive sentiment.
Billionaire David E. Shaw’s 10 Small-Cap Stock Picks with Huge Upside Potential
David E. Shaw is one billionaire investor whose record speaks for itself on Wall Street. Having founded D.E. Shaw & Co., L.P.
11 Worst Performing Stocks in S&P 500 So Far in 2025
After a two-year surge of 53%, marking the best performance for the broad market index since the 1997-98 rally, stocks have been taken for a wild ride in 2025 due to uncertainties...
10 Best Long Term Growth Stocks to Buy According to Billionaires
As per Barclays, the US administration announced numerous executive orders with reforms associated with world trade, immigration, and global geopolitics, resulting in elevated...
Jim Cramer Says Wait A Little & Discusses These 11 Stocks
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer commented on the increasing bearishness in the stock market.
8 Best Gene-Editing Stocks to Buy
Gene editing is an advanced medical technique within gene therapy that involves precisely modifying an individual’s DNA to treat or prevent diseases.
Jim Cramer Discussed These 9 Stocks Recently
“It's time to praise the winners, the ones that don't need to wait until April 2nd to find out whether their business will be slammed by tariffs when President Trump announces...
Did Jim Cramer Nail or Miss These 14 Stocks?
During the most recent episode of Mad Money, Jim Cramer described the current stock market as a “short sellers paradise,” offering an ideal moment for those betting against...
12 Most Promising Biotech Stocks According to Wall Street Analysts
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
10 Stocks with Potential to Explode in 2025
The recent pullback in US equities can be a sign of an aging bull market and a reaction to developments happening around trade policy, as per Jurrien Timmer, Director of Global...
10 Best Vaccine Stocks to Buy According to Hedge Funds
On February 24, CNBC reported that President Trump declared that sweeping US tariffs on imports from Mexico and Canada “will go forward” in a statement before the expiry of...
12 Best Healthcare Stocks to Buy According to Analysts
McKinsey reported that, since 2019, the US healthcare industry witnessed significant financial pressure.
12 Best S&P 500 Stocks to Invest in According to Analysts
2024 was a memorable year for the broad market index, which posted a gain of 23.31%, building on the 24.2% return in 2023.
Jim Cramer Recently Discussed These 17 Stocks And Chinese Hackers
Jim Cramer's appearance on Squawk on the Street aired on January 17th covered a wide variety of topics.
Jim Cramer Recently Discussed These 15 Stocks & The California Wildfires
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer commented on the devastation ushered in by the California wildfire calamity, social media CEO Mark Zuckerberg...
11 Stocks That Will Go to the Moon According to Reddit
The earnings season is upon us and the investors are excited to see how the market sets the pace for the rest of 2025.
10 S&P 500 Stocks on Jim Cramer’s Radar
Jim Cramer, host of Mad Money, recently discussed the current state of the market and also discussed both the leading and lagging stocks within the S&P 500.
10 Firms Post Strong Gains Amid Wall Street Bloodbath
Shares of Sibanye Stillwater grew by 4.78 percent on Tuesday, adding $0.16 to close at $3.51 each as investor sentiment was boosted by news citing aides of incoming president ...
10 Firms End 2024 Stronger With Impressive Gains
The Dow Jones Industrial Average dipped by 0.07 percent, the S&P 500 shed 0.43 percent, and the Nasdaq Composite declined by 0.90 percent.
14 Stocks That Jim Cramer Recently Talked About
In his latest appearance on CNBC's Squawk on the Street, Jim Cramer continued to talk about the incoming Trump administration's tariffs.
10 Stocks That Will Bounce Back According To Hedge Funds
With 2024 coming to a close, investors have left several unknown variables behind them.
10 High Growth Healthcare Stocks to Invest in Now
During lean economic times, investing in healthcare stocks is generally regarded as defensive.
10 Worst Performing Healthcare Stocks in 2024
The healthcare industry remains a vital and resilient sector which is driven by advancements in technology, increasing global demand, and an aging population.
10 Oversold Healthcare Stocks To Invest In
Investing in healthcare stocks during lean economic times is generally regarded as defensive.
10 Most Promising Cancer Stocks According to Hedge Funds
According to the World Health Organization (WHO), cancer remains one of the leading causes of death globally, responsible for nearly 10 million deaths in 2020, or about one in...
10 Worst Performing Biotech Stocks in 2024
Biotechnology stocks are among the most volatile in the market due to their high risk.
Goldman Sachs’ Top Growth Investors: 34 Stocks With The Highest Investment For Growth
With the 2024 US Presidential Election having come to a close, Wall Street can now focus on the future of artificial intelligence, the Federal Reserve's interest rate cut cycle...
12 High Growth Large Cap Stocks to Buy Now
BlackRock highlighted that its portfolio managers are broadly optimistic about US equities.
10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds
The pharmaceutical industry remains a hub of patent innovation, driven by evolving treatment paradigms, unmet medical needs, and the rising influence of technologies like pharmacogenomics...
10 Worst Performing Stocks in S&P 500 in 2024
Since 2023, the market has experienced extended winning streaks, reflecting the economy's resilience.
10 Best Depressed Stocks To Buy Heading into 2025
In one of our recent articles about 10 High Growth Non-Tech Stocks That Are Profitable in 2024, we talked about how the US market has continued to show resilience against economic...
10 Worst Performing NASDAQ Stocks in 2024
Markets have been soaring for the better part of the year, with pullbacks acting as entry levels from where investors have joined and pushed the market higher.
10 Best QQQ Stocks to Buy According to Analysts
Several recent discussions have focused solely on the implications of the Fed's recent rate cut for the market.
Goldman Sachs’ List Of Stocks That Hedge & Mutual Funds Love & Hate: 28 Stocks On The Mutual and Hedge Funds Radar
The surge in interest surrounding artificial intelligence has meant that the stock market in 2024 has continued to surprise.
10 Most Promising Biotech Stocks According to Hedge Funds
Biotechnology stocks are known for their high risk, making them some of the most volatile in the market.
Jim Cramer’s List of Stocks that Finished Dead Last
In a recent episode of Mad Money, Jim Cramer examined market trends of the third quarter.
10 Worst Performing Stocks to Buy on the Dip
Capital markets demonstrated increased volatility starting in August 2024 and continuing in September 2024.
Jim Cramer’s Latest Portfolio: Top 9 Stocks to Buy and Sell
The CNBC host said that he has reminded his viewers repeatedly that when the Fed is your “enemy” you should stick to recession-proof stocks that can produce consistent earnings...
